SYNACT PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.84 SEK | -0.94% |
|
-8.68% | -22.54% |
| Mar. 20 | Sweden's SynAct Pharma Names New CEO | MT |
| Mar. 20 | SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting | CI |
Chart calendar SynAct Pharma AB
2b99e134bc2d5b6ca06.knr7v6dLGoiQlz43NyTn1qxm2zcWbBJ1qShHezeVP7Y.vxe31-w_aPjW-0h1c06MoZ45nA51Wnognx0sPwfCBv_3I4LTlSV0vPqnBg~fd42f5b06b76b16ff7ad24b6c64d1526
Upcoming events on SynAct Pharma AB
Past events on SynAct Pharma AB
| 2024-03-20 04:30 am | Extraordinary Shareholders Meeting |
| 2024-02-23 09:00 am | Q4 2023 Earnings Call |
| 2024-02-22 | Q4 2023 Earnings Release |
| 2023-09-13 09:00 am | Business Update Call |
| 2023-08-03 | Q2 2023 Earnings Release |
| 2023-07-03 | Basic & Clinical Pharmacology World Congress |
| 2023-05-30 12:00 am | ABGSC Life Science Summit |
| 2023-05-24 | Annual General Meeting |
| 2023-05-04 | Q1 2023 Earnings Release |
| 2023-02-16 | FY 2022 Earnings Release |
| 2022-11-03 | Q3 2022 Earnings Release |
| 2022-08-04 | Interim 2022 Earnings Release |
| 2022-05-19 | Annual General Meeting |
| 2022-05-05 | Q1 2022 Earnings Release |
| 2022-02-10 | FY 2021 Earnings Release |
| 2022-01-09 | JP Morgan Healthcare Conference |
| 2021-12-07 | ABGSC Investor Days |
| 2021-12-06 | Sedermeradagen Conference |
| 2021-11-30 09:00 am | AP1189 Phase 2a BEGIN Study Results Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 0,00 - |
|
EBITDA Million SEK | Released Forecast Spread | -23,7 -27,0 12.06% | 0,00 | 0,00 | 0,00 | -224 -160 -39.88% |
|
EBIT Million SEK | Released Forecast Spread | -24,1 -27,0 10.81% | 0,00 | 0,00 | 0,00 | -224 -160 -39.88% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -27,1 -27,0 -0.39% | 0,00 | 0,00 | 0,00 | -224 -161 -39.39% |
|
Net income Million SEK | Released Forecast Spread | -24,0 -24,0 0.18% | -26,6 | -69,3 | -99,2 | -216 -152 -41.58% |
|
EPS SEK | Released Forecast Spread | -1,35 -1,21 -11.57% | -1,23 | -2,68 | -3,60 | -6,64 -1,55 -329.02% |
| Announcement Date | 11/02/20 | 19/04/21 | 11/02/22 | 17/02/23 | 23/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | |||
|
EBITDA Million SEK | Released Forecast Spread | -24,0 | -91,1 -27,0 -237.27% | ||
|
EBIT Million SEK | Released Forecast Spread | -31,7 -24,0 -32.05% | -91,1 -27,0 -237.27% | ||
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -32,0 -24,1 -32.73% | -90,5 -27,1 -234.1% | ||
|
Net income Million SEK | Released Forecast Spread | -26,2 | -43,5 | -31,9 -24,1 -32.27% | -90,5 -27,1 -234.11% |
|
EPS SEK | Released Forecast Spread | -1,01 | -1,37 | -1,00 -0,76 -32.04% | -2,58 -0,76 -238.64% |
| Announcement Date | 11/02/22 | 04/08/23 | 24/10/23 | 23/02/24 |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
Past sector events for SynAct Pharma AB
| Today 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| Today 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| Today 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| Today | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| Today | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| Today | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| Today | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 04:01 pm | MORPHOSYS AG: Q1 2024 Earnings Release |
Quarterly earnings - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYNACT Stock
- Calendar SynAct Pharma AB
